Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion type Assertion NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_head.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion description "[Furthermore, human AFAR1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (GHB) and was found elevated in neurodegenerative diseases such as Alzheimer's and dementia with Lewy bodies (DLB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion evidence source_evidence_literature NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion SIO_000772 18752886 NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion wasDerivedFrom befree-2016 NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.
- NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_assertion wasGeneratedBy ECO_0000203 NP690112.RAZ5lSDiYgEjENGxxLqeqQmlY2eI42n4JEG9SYchVd1w0130_provenance.